[ Back to EurekAlert! ]

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine

Reprogramming Cells to Fight Diabetes

Caption: Treatment of human islets with the histone methyltransferase inhibitor Adox results in co-localization of the beta-cell specific transcription factor PDX1 (white) in a substantial sub-population of glucagon-positive cells (red), indicating partial endocrine cell-fate conversion.

Credit: Nuria Bramswig, Perelman School of Medicine, University of Pennsylvania

Usage Restrictions: None

Related news release: Reprogramming cells to fight diabetes


[ Back to EurekAlert! ]